Estrogen Receptor Status
1 clinical trials · Condition
◉ Watch Estrogen Receptor Status
| Record | Firm | Date |
|---|---|---|
| Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer (NCT02860000) | Mayo Clinic | 2017-07-06 |
Track Estrogen Receptor Status automatically
Every clearance here is in the API, with alerts when new ones post.